The commensal urinary microbiome as a predictor of response to Bacillus Calmette-Guerin (BCG) immunotherapy in non-muscle invasive bladder cancer

被引:0
|
作者
Sweis, Randy F. [1 ]
Golan, Shay [2 ]
Barashi, Nimrod [1 ]
Hill, Elle [1 ]
Andolfi, Ciro [1 ]
Werntz, Ryan [1 ]
Bloodworth, Jeffrey [1 ]
Gajewski, Thomas [1 ]
Steinberg, Gary D. [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Rabin Med Ctr, Petah Tiqwa, Israel
关键词
D O I
10.1158/1538-7445.SABCS18-2836
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2836
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Bacillus Calmette-Guerin (BCG) Treatment Failures with Non-Muscle Invasive Bladder Cancer: A Data-Driven Definition for BCG Unresponsive Disease
    Steinberg, Ryan L.
    Thomas, Lewis J.
    Mott, Sarah L.
    O'Donnell, Michael A.
    [J]. BLADDER CANCER, 2016, 2 (02) : 215 - 224
  • [32] Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guerin Immunotherapy Unresponsive Non-Muscle Invasive Bladder Cancer
    Joshi, Mrinmayee
    Atlas, Steven J.
    Beinfeld, Molly
    Chapman, Richard H.
    Rind, David M.
    Pearson, Steven D.
    Touchette, Daniel R.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : 823 - 832
  • [33] Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Alam, Syed M.
    Larson, Matthew
    Srinivasan, Pugazhendhi
    Genz, Nick
    Fleer, Ryan
    Sardiu, Mihaela
    Thompson, Jeffrey
    Lee, Eugene
    Hamilton-Reeves, Jill
    Wulff-Burchfield, Elizabeth
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 431.e15 - 431.e20
  • [34] FAILURE OF BACILLUS CALMETTE-GUERIN THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: DEFINITION AND TREATMENT OPTIONS
    Gual Frau, Josep
    Palou, Joan
    Rodriguez, Oscar
    Parada, Ruben
    Breda, Alberto
    Villavicencio, Humberto
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (07): : 423 - 433
  • [35] Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guerin immunotherapy in patients with urothelial non-muscle invasive bladder cancer
    Di Maida, Fabrizio
    Grosso, Antonio A.
    Tellini, Riccardo
    Lambertini, Luca
    Lo Re, Mattia
    Cadenar, Anna
    Giudici, Sofia
    Giorgione, Roberta
    Rossi, Virginia
    Antonuzzo, Lorenzo
    Minervini, Andrea
    Mari, Andrea
    [J]. MINERVA UROLOGY AND NEPHROLOGY, 2022, 74 (05): : 642 - 646
  • [36] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898
  • [37] Analysis of sex-based differences to Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Fadel, Jonathan
    Simonyan, David
    Fradet, Vincent
    Lodde, Michele
    Lacombe, Louis
    Fradet, Yves
    Toren, Paul
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (12) : 539.e1 - 539.e8
  • [38] Can bacillus Calmette-Guerin immunotherapy prevent progression in non-muscle-invasive bladder cancer?
    Fujii, Yasuhisa
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (05) : 441 - 441
  • [39] Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy
    Bacon, Jack V. W.
    Muller, David C.
    Ritch, Elie
    Annala, Matti
    Dugas, Sarah G.
    Herberts, Cameron
    Vandekerkhove, Gillian
    Seifert, Helge
    Zellweger, Tobias
    Black, Peter C.
    Bubendorf, Lukas
    Wyatt, Alexander W.
    Rentsch, Cyrill A.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (06): : 677 - 686
  • [40] A study of intravesical bacillus Calmette-Guerin (BCG) in combination with ALT-803 in patients with non-muscle invasive bladder cancer.
    Rosser, Charles Joel
    Chamie, Karim
    Rock, Amy
    Ferguson, Lydia
    Wong, Hing C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)